إعلان
إعلان

LLY

LLY logo

Eli Lilly & Co.

1064.04
USD
برعاية
+22.50
+2.16%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

1064.87

+0.83
+0.08%

تقارير أرباح LLY

النسبة الإيجابية المفاجئة

LLY تفوق 27 من 39 آخر التقديرات.

69%

التقرير التالي

بيانات التقرير القادم
٠٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$17.96B
/
$7.14
التغير الضمني من Q3 25 (Revenue/ EPS)
+2.06%
/
+1.71%
التغير الضمني من Q4 24 (Revenue/ EPS)
+32.74%
/
+34.21%

Eli Lilly & Co. earnings per share and revenue

On ٣٠ أكتوبر ٢٠٢٥, LLY reported earnings of 7.02 USD per share (EPS) for Q3 25, beating the estimate of 5.75 USD, resulting in a 22.05% surprise. Revenue reached 17.60 مليار, compared to an expected 16.18 مليار, with a 8.81% difference. The market reacted with a +3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 المحللين forecast an EPS of 7.14 USD, with revenue projected to reach 17.96 مليار USD, implying an زيادة of 1.71% EPS, and زيادة of 2.06% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Eli Lilly & Co. reported EPS of $7.02, beating estimates by 22.05%, and revenue of $17.60B, 8.81% above expectations.
The stock price moved up 3.81%, changed from $813.53 before the earnings release to $844.50 the day after.
The next earning report is scheduled for ٠٤ فبراير ٢٠٢٦.
Based on 20 المحللين, Eli Lilly & Co. is expected to report EPS of $7.14 and revenue of $17.96B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان